Epidemiologic and ecologic features of blastomycosis: A review

被引：28
作者：
Kaitlin Benedict
Monika Roy
Tom Chiller
Jeffrey P. Davis
机构：
[1] Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333
[2] Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health, Madison, WI
来源：
Current Fungal Infection Reports | 2012年 / 6卷 / 4期
关键词：
Blastomyces; Blastomycosis; Ecology; Epidemiology; Fungus; Prevention; Risk factor;
D O I：
10.1007/s12281-012-0110-1
中图分类号：
学科分类号：
摘要：
Blastomycosis is a potentially fatal infection caused by Blastomyces dermatitidis, a fungus endemic to North America in areas surrounding the Ohio and Mississippi River valleys and the Great Lakes. The clinical manifestations, diagnostic techniques, and treatment strategies for blastomycosis are relatively well-described in the literature; however, the epidemiologic features of disease are not as clearly defined as those of other endemic mycoses, such as histoplasmosis and coccidioidomycosis. We review the ecologic and epidemiologic aspects of B. dermatitidis and blastomycosis, including geographic distribution, environmental niche, seasonality, and possible risk factors. © 2012 Springer Science+Business Media, LLC.
引用
收藏
页码：327 / 335
页数：8
相关论文
共 85 条
[11]  
Klein B.S., Kuritsky J.N., Chappell W.A., Et al., Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis, Am Rev Respir Dis, 133, 1, pp. 144-148, (1986)
[12]  
Klein B.S., Vergeront J.M., Kaufman L., Et al., Serological tests for blastomycosis: Assessments during a large point-source outbreak in Wisconsin, J Infect Dis, 155, 2, pp. 262-268, (1987)
[13]  
Turner S., Kaufman L., Jalbert M., Diagnostic assessment of an enzyme-linked immunosorbent assay for human and canine blastomycosis, J Clin Microbiol, 23, 2, pp. 294-297, (1986)
[14]  
Bariola J.R., Hage C.A., Durkin M., Et al., Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis, Diagn Microbiol Infect Dis, 69, 2, pp. 187-191, (2011)
[15]  
Babady N.E., Buckwalter S.P., Hall L., Le Febre K.M., Binnicker M.J., Wengenack N.L., Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR, J Clin Microbiol, 49, 9, pp. 3204-3208, (2011)
[16]  
Sidamonidze K., Peck M.K., Perez M., Et al., Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue, J Clin Microbiol, 50, 5, pp. 1783-1786, (2012)
[17]  
Klein B.S., Jones J.M., Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients, J Clin Invest, 85, 1, pp. 152-161, (1990)
[18]  
Klein B.S., Jones J.M., Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen, Infect Immun, 62, 9, pp. 3890-3900, (1994)
[19]  
Soufleris A.J., Klein B.S., Courtney B.T., Proctor M.E., Jones J.M., Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents, Clin Infect Dis, 19, 1, pp. 87-92, (1994)
[20]  
Chapman S.W., Dismukes W.E., Proia L.A., Et al., Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America, Clin Infect Dis, 46, 12, pp. 1801-1812, (2008)
123456789